895240-50-3

Basic information

• Product Name: 4-Methoxy-3-(3-methoxypropoxyl)benzoic acid
• Synonyms: 3-(3-Methoxypropoxy)-4-methoxybenzoic acid;4-Methoxy-3-(3-methoxypropoxyl)benzoic acid;Benzoic acid,4-Methoxy-3-(3-Methoxypropoxy)-
• CAS NO: 895240-50-3
• Molecular Formula: C₁₂H₁₆O₅
• Molecular Weight: 240.25
• EINECS: 1533716-785-6
• Mol File: 895240-50-3.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Density: 1.167
• CAS DataBase Reference: 4-Methoxy-3-(3-methoxypropoxyl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Methoxy-3-(3-methoxypropoxyl)benzoic acid(895240-50-3)
• EPA Substance Registry System: 4-Methoxy-3-(3-methoxypropoxyl)benzoic acid(895240-50-3)

Safety Data

• Hazardous Substances Data: 895240-50-3(Hazardous Substances Data)

Usage

General Description

4-Methoxy-3-(3-methoxypropoxyl)benzoic acid (also known as 4-Anisic acid 3-[(3-methoxypropoxy)methyl] ester) is a chemical compound categorized as an organic substance. It mainly consists of carbon, oxygen, and hydrogen atoms. 4-Methoxy-3-(3-methoxypropoxyl)benzoic acid can be produced synthetically in a laboratory setting and is often utilized for research purposes, especially within the field of organic chemistry. Although specific applications and properties of this chemical are not commonly reported, like other types of benzoic acid derivatives, it could potentially be applied in the synthesis of certain pharmaceuticals or bioactive compounds. Its safety, toxicity, or environmental impact have not been studied extensively thus far.

Upstream product

• 895240-49-0 4-methoxy-3-(3-methoxy-propoxy)-benzoic acid methyl ester 
• 6702-50-7 3-hydroxy-4-methoxybenzoate 

Downstream Products

• 895245-26-8 (3S,4R)-3-(tert-butyl-dimethyl-silanyloxymethyl)-4-({isopropyl-[4-methoxy-3-(3-methoxy-propoxy)-benzoyl]-amino}-methyl)-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 895240-48-9 4-methoxy-3-(3-methoxypropoxy)benzoyl chloride 
• 911114-86-8 (3S,4R)-3-[(cyclohexylmethyl-methyl-carbamoyloxy)-methyl]-4-({isopropyl-[4-methoxy-3-(3-methoxy-propoxy)-benzoyl]-amino}-methyl)-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 911113-73-0 (3R,4R)-3-({isopropyl-[4-methoxy-3-(3-methoxy-propoxy)-benzoyl]-amino}-methyl)-4-[(2-methyl-2-phenyl-propionylamino)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 911113-78-5 (3R,4R)-3-aminomethyl-4-({isopropyl-[4-methoxy-3-(3-methoxy-propoxy)-benzoyl]-amino}-methyl)-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 895245-25-7 (3S,4R)-3-hydroxymethyl-4-({isopropyl-[4-methoxy-3-(3-methoxy-propoxy)-benzoyl]-amino}-methyl)-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 1187941-65-6 C₃₄H₅₁N₃O₈ 

Relevant articles and documents

AMIDE DERIVATIVE

The present invention relates to a compound of the formula (I) being useful as a renin inhibitor, or a pharmaceutically acceptable salt thereof. wherein R1a is a hydrogen atom, an optionally substituted C1-6 alkyl, etc.; R1b is an optionally substituted C1-6 alkoxy, etc.; R1c is a hydrogen atom, an optionally substituted C1-6 alkoxy, etc.; R2 is a hydrogen atom, an optionally substituted C1-6 alkyl, etc.; R3a, R3b, R3c and R3d are independently the same or different, and each is a group of the formula: -A-B (in which A is a single bond, -(CH2)sO-, - (CH2)sN(R4)CO-, etc., B is a hydrogen atom, an optionally substituted C1-6 alkyl, etc.), etc.; R4 is a hydrogen atom, an optionally substituted C1-6 alkyl, etc.; s is 0, etc.; and n is 1, etc.

3, 4-SUBSTITUTED PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION

The invention relates to the use of (3,4-di-, 3,3,4-tri, 3,4,4-tri- or 3,3,4,4-tetra-)substituted pyrrolidine compounds for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; compounds that are part of a subclass of these substituted pyrrolidine compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (= disorder) that depends on activity of renin; new compounds that are part of a subclass of these substituted pyrrolidine compounds; pharmaceutical formulations comprising said substituted pyrrolidine compounds, and/or a method of treatment comprising administering said substituted pyrrolidine compounds, a method for the manufacture especially of said new substituted pyrrolidine compounds, as well as novel intermediates, starting materials and/or partial steps for their synthesis. The substituted pyrrolidine compounds are of the formula (I), wherein R1, R2, R3, R4, R5 and T are defined as in the specification.